PharmaShots | Incisive News in 3 Shots

Subscribe Now

marketing application

Roche Reports EMA and FDA's Acceptance of Marketing Application for Satralizumab to Treat Neuromyelitis Optica Spectrum Disorder

Roche Reports EMA and FDA's Acceptance of Marketing Application for Satralizumab to Treat Neuromyelitis Optica Spectrum Disorder

October 30, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us